PipelineTime to Take Your Medicines, Seriously
References (42)
- et al.
Compliance with topical pilocarpine treatment
Am J Ophthalmol
(1986) - et al.
Compliance with topical timolol treatment
Am J Ophthalmol
(1987) Pipeline: Treatment adherence in ophthalmology and astrophysics
Ocul Surf
(2010)- et al.
Pipeline: Where do unused medications go when they die?
Ocul Surf
(2013) Pipeline: Can I use those eyedrops after the expiration date?
Ocul Surf
(2015)- et al.
Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery
Ophthalmology
(2001) - et al.
Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients
Ophthalmology
(2009) Time to take our medicines, seriously
Pharm Weekbl
(1992)Dispenser for pharmaceuticals having patient compliance monitor apparatus: Alza Corporation
(1977)Treatment adherence
Br J Psychiatry
(1976)
Why do people (still) go blind from glaucoma?
Transl Vis Sci Technol
(2015)
Why do some people go blind from glaucoma?
Ophthalmology
(1982)
A new taxonomy for describing and defining adherence to medications
Br J Clin Pharmacol
(2012)
Primary medication non-adherence: analysis of 195,930 electronic prescriptions
J Gen Intern Med
(2010)
Adherence to medications: Insights arising from studies on the unreliable link between prescribed and actual drug dosing histories
Ann Rev Pharm Toxicol
(2011)
An objective evaluation of eye-drop instillation in glaucoma patients
Arch Ophthalmol
(2009)
Early Refill Edits on Topical Ophthalmic Products
(2013)
Health Insurance – Prescription Eye Drops – Refills
(2013)
Prostaglandin-associated periorbitopathy
Cataract Refract Surg Today
(2011)
Prostaglandin-associated periorbitopathy in latanoprost users
Clin Ophthalmol
(2014)
Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy
Invest Ophthalmol Vis Sci
(2014)
Cited by (0)
Disclosure: Gary D. Novack, PhD consults with numerous pharmaceutical firms.
© 2016 Elsevier Inc. All rights reserved.